More on IDXX
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $553.48 |
|
|||
| Open | $562.01 | ||||
| 52 Wk High | $117.84 | ||||
| 52 Wk Low | $63.48 | ||||
| Day High | $568.67 | ||||
| Day Low | $558.39 | ||||
| P/E | 162.86 | ||||
| EPS | $3.48 | ||||
| Volume | 430,105 | ||||
- Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX
- IDEXX Laboratories (IDXX) PT Lowered to $750 at JPMorgan
- Goldman Sachs Starts IDEXX Laboratories (IDXX) at Buy
- KeyBanc Starts IDEXX Laboratories (IDXX) at Sector Weight
- Piper sees veterinary medicine challenges continuing through 2027
- IDEXX Laboratories to Release 2026 Third Quarter Financial Results
- Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
- IDEXX Laboratories (IDXX) Reiterated at Buy by Stifel Post Veterinarian Survey
- IDEXX adds tapeworm detection to UK faecal testing platform
- IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
Entities mentioned with IDXX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Stifel | View Related Stories »
- Trading Radar | View Related Stories »
- Show More...
